SULLIVAN TABLES Flashcards
1
Q
CHARACTERIZED BY DISCRETE ATTACKS OF NEUROLOGICAL DEFICITS WITH EITHER FULL OR PARTIAL RECOVERY IN SUBSEQUENT WEEKS TO MONTHS
A
RELAPSING REMITTING MS
2
Q
% OF RELAPSING REMITTING MS
A
85%
3
Q
CHARACTERIZED BY LACK OF DISEASE PROGRESSION
A
RELAPSING REMITTING MS
4
Q
MAY BE THE RESULT OF PROGRESSIVE AXONAL LOSS RATHER THAN NEW LESIONS
A
SECONDARY PROGRESSIVE MS
5
Q
CHARACTERIZED BY DISEASE PROGRESSION AND STEADY FUNCTIONAL DECLINE FROM ONSET, PT. MAY EXPERIENCE MODEST FLUCTUATIONS IN NEUROLOGICAL DISABILITY BUT DISCRETE ATTACK DO NOT OCCUR
A
PRIMARY PROGRESSIVE MS
6
Q
PRIMARY PROGRESSIVE MS %
A
10%
7
Q
CHARACTERIZED BY STEADY DETERIORATION IN DISEASE FROM ONSET BUT WITH OCCASIONAL ACUTE ATTACKS
A
PROGRESSIVE RELAPSING MS
8
Q
% OF PROGRESSIVE RELAPSING MS
A
5%
9
Q
STABLE PATIENT MAY HAVE LOCAL INFLAMMATORY ACTIVITY THAT IS CLINICALLY ABSENT
A
RELAPSING REMITTING
10
Q
ASSOCIATED WITH LATER ONSET (MEAN 40Y/O) AND MORE EQUAL GENDER DISTRIBUTION
A
PRIMARY PROGRESSIVE MS
11
Q
INTERVALS IN BETWEEN ATTACKS ARE CHARACTERIZED BY CONTINUING DISEASE PROGRESSION
A
PROGRESSIVE RELAPSING MS
12
Q
DEGENERATION OF CORTICOSPINAL TRACTS, NEURONS IN THE MOTOR CORTEX AND BRAINSTEM AND ANTERIOR HORN CELLS IN THE SC
A
ALS
13
Q
DEGENERATION OF UMN
A
PRIMARY LATERAL SCLEROSIS
14
Q
DEGENERATION OF MOTOR NEURONS OF CN 9-12
A
PROGRESSIVE BULBAR PALSY
15
Q
LOSS OR CHROMATOLYSIS OF MOTOR NEURONS OF THE SC AND BRAINSTEM
A
PROGRESSIVE MUSCULAR ATOPHY
16
Q
STAGE 1 HOEHN YAHR
A
MINIMAL/ABSENT ; UNILAT
17
Q
STAGE 2 HOEHN YAHR
A
MINIMAL/BILATERAL/MIDLINE INVOLVEMENT, BALANCE INTACT
18
Q
STAGE 3 HOEHN YAHR
A
IMPAIRED RIGHTING REFLEXES
19
Q
STAGE 4 HOEHN YAHR
A
ALL SX PRESENT AND SEVERE, STANDING AND WALKING ONLY POSSIBLE WITH ASSIST
20
Q
STAGE 5 HOEHN YAHR
A
CONFINED TO BED/W/C
21
Q
pt. reacts inconsistently and nonpurposefully to stimuli in a nonspecific manner
A
GENERALIZED RESPONSE RLA 2
22
Q
PT. APPEARS TO BE IN A DEEP SLEEP AND IS COMPLETELY UNRESPONSIVE TO STIMULI
A
RLA 1 NO RESPONSE
23
Q
PT. REACTS SPECIFICALLY BUT INCONSISTENTLY TO STIMULI, MAY FOLLOW SIMPLE COMMAND SUCH AS CLOSING EYES IN AN INCONSISTENT DELAYED MANNER
A
RLA 3 LOCALIZED RESPONSE
24
Q
HEIGHTENED STATE OF ACTIVITY, BIZARRE AND NON-PURPOSEFUL BEHAVIOR
A
RLA 4 CONFUSED AGIT
25
CONFABULATION PRESENT, DOES NOT DISCRIMINATE BETWEEN OBJECTS AND PERSONS.
RLA 4 CONFUSED AGIT
26
ABLE TO RESPOND TO SIMPLE COMMANDS FAIRLY CONSISTENTLY BUT RESPONSES ARE NON PURPOSEFUL OR FRAGMENTED WITH INC COMPLEXITY
RLA 5 CONFUSED INAPPROPRIATE
27
GOAL DIRECTED BEHAVIOR BUT IS DEPENDENT ON EXTERNAL INPUT OR DIRECTION
RLA 6 CONFUSED APP
28
GROSS ATTENTION TO ENVIRONMENT BUT IS HIGHLY DISTRACTIBLE AND LACKS ABILITY TO FOCUS ATTENTION ON A SPECIFIC TASK
RLA V
29
FOLLOWS SIMPLE DIRECTIONS CONSISTENTLY AND SHOWS CARRYOVER FOR RELEARNED TASKS SUCH AS SELF CARE
RLA VI
30
PAST MEMORIES SHOW MORE DEPTH AND DETAIL THAN RECENT MEMORY
RLA VI
31
PT APPEARS APPROPRIATE AND ORIENTED WITHIN HOSPITAL/HOME; ROBOT LIKE
RLA VII
32
SHOWS CARRYOVER FOR NEW LEARNING BUT AT A DECREASED RATE, JUDGMENT REMAINS IMPAIRED
RLA VII
33
BLUISH GRAY DISCOLORATION OF THE SKIN AND MUCUS MEMBRANE
CYANOSIS
34
REDDENED AREA OF SKIN D/T INCREASED BLOOD FLOW
ERYTHEMA
35
DIFFUSED REDNESS OF FACE RELATED TO EMOTION, FEVER AND INC TEMPERATURE
FLUSHING
36
TINY RED OR PURPLE HEMORRHAGIC SPOTS D/T CAPILLARY BLEEDING
PETECHIAE
37
NO PERCEPTIBLE PULSE EVEN WITH MAX PRESSURE
ABSENT - 0
38
BARELY PERCEPTIBLE , EASILY OBLITERATED WITH SLIGHT PRESSURE, FADES IN AND OUT
THREADY - 1+
39
DIFFICULT TO PALPATE, OBLITERATED WITH SLIGHT PRESSURE
WEAK - 2+
40
EASY TO PALPATE, REQUIRES MOD PRESSURE TO OBLITERATE
NORMAL 3+
41
VERY STRONG HYPERACTIVE, IS NOT OBLITERATED WITH MOD PRESSURE
BOUNDING 4+
42
ALTERNATES B/W PERIOD OF FEVER AND PERIOD OF NORMAL TEMPERATURE
INTERMITTENT
43
FLUCTUATES MORE THAN 3.6 F OR 2 C within a 24 hr period but remains above normal
REMITTENT
44
PERIODS OF FEVER ARE INTERSPERSED WITH NORMAL TEMP, EACH LAST AT LEAST ONE DAY AKA RECURRENT FEVER
RELAPSING
45
BODY TEMP MAY FLUCTUATE SLIGHTLY BUT IS CONSTANTLY ABOVE NORMAL
CONSTANT
46
MAS 0
NO INCREASE IN MM TONE
47
MAS 1
SLIGHT INCREASE IN MM TONE , MANIFESTED BY A CATCH AND RELEASE OR BY MIN RESISTANCE AT THE END OF THE ROM
48
MAS 1+
SLIGHT INCREASE IN MM TONE, WITH A CATCH, FOLLOWED BY MINIMAL RESISTANCE THROUGHOUT REMAINDER (< HALF OF ROM)
49
MAS 2
MORE MARKED INCREASED IN MM TONE BUT AFFECTED PART STILL EASILY MOVED
50
MAS 3
MARKED INCREASE IN MM TONE , PASSIVE MVT IS DIFFICULT
51
MAS 4
AFFECTED PART RIGID IN FLEXION OR EXTENSION
52
RAPID UPSTROKE AND DOWNSTROKE AND A SHORTENED PEAK
CORRIGAN'S / WATER HAMMER PULSE
53
REGULAR PULSE RHYTHM WITH ALTERNATION OF WEAK AND STRONG BEATS
PULSUS ALTERNANS
54
IRREGULAR PULSE RHYTHM IN WHICH PREMATURE BEATS ALTERNATE WITH SINUS BEATS
PULSUS BIGEMINUS
55
A STRONG UPSTROKE, DOWNSTROKE AND A SECOND UPSTROKE DURING SYSTOLE
PULSUS BISFERIENS
56
PULSE WITH A MARKEDLY DECREASED AMPLITUDE DURING INSPIRATION
PULSUS PARADOXUS
57
PULSUS BISFERIENS INDICATES?
AORTIC INSUFFICIENCY, AORTIC REGURGITATION AND AORTIC STENOSIS
58
CORRIGAN'S PULSE / WATER HAMMER PULSE
PATENT DUCTUS ARTERIOSUS
59
PULSUS PARADOXUS MAY INDICATE?
PERICARDIAL TAMPONADE
60
NORMAL RESPIRATIONS WITH EQUAL RATE AND DEPTH 12-20 CPM
EUPNEA
61
REGULAR BUT ABNORMALLY DEEP AND INCREASE IN RATE
KUSSMAUL'S RESPIRATION
62
IRREGULAR SHALLOW ALTERNATING WITH PERIODS OF APNEA
BIOT'S
63
GRADUAL INCREASE IN DEPTH FOLLOWED BY GRADUAL DECREASE AND THEN A PERIOD OF APNEA
CHEYNE-STOKES BREATHING
64
APNEA
THE ABSENCE OF BREATHING
65
SENSATION EXPERIENCED AT A SITE REMOTE FROM POINT OF STIMULATION
ALLESTHESIA
66
PAINFUL BURNING SENSATION ALONG THE DISTRIBUTION OF NN
CAUSALGIA
67
PAIN PRODUCED BY A NON NOXIOUS STIMULUS
ALLODYNIA
68
LOSS OF LIGHT TOUCH SENSIBILITY
THIGMANESTHESIA
69
TOUCH SENSATION PERCEIVED AS PAIN
DYSESTHESIA
70
ACCESSORY JT MOTION: ANKYLOSED JT
GRADE 0
71
ACCESSORY JT MOTION: CONSIDERABLE HYPOMOBILITY
GRADE 1
72
ACCESSORY JT MOTION: SLIGHT HYPOMOBILITY
GRADE 2
73
WHAT ACC JT MOTION GRADE/S IS GRADE 1 AND 2 JT MOB INDICATED?
GRADE 1 AND 2
74
ACCESSORY JT MOTION: NORMAL
GRADE 3
75
ACCESSORY JT MOTION: SLIGHT HYPERMOBILITY
GRADE 4
76
ACCESSORY JT MOTION: CONSIDERABLE HYPERMOBILITY
GRADE 5
77
ACCESSORY JT MOTION: UNSTABLE
GRADE 6
78
ACCESSORY JT MOTION: JT MOB IS NOT INDICATED AND SURGERY SHOULD BE CONSIDERED?
GRADE 0 AND GRADE 6
79
ATLEAST 50% BUT NOT FULL ROM AGAINST GRAVITY
3 -
80
LIGAMENTOUS INSTABILITY: GRADE 1
0-5 mm
81
LIGAMENTOUS INSTABILITY: GRADE 2
6-10 mm
82
LIGAMENTOUS INSTABILITY: GRADE 3
11-15 mm
83
LIGAMENTOUS INSTABILITY: GRADE 4
> 15 mm
84
PNS/SNS: hypervigilance
SNS
85
PNS/SNS: PUPILS CONSTRICT
PNS
86
PNS/SNS: HR DECREASES
PNS
87
PNS/SNS: GLUCOSE PRODUCTION AND RELEASE INCREASES
SNS
88
PNS/SNS: DIGESTION SLOWS
SNS
89
PNS/SNS: DIGESTION RETURNS
PNS
90
PNS/SNS: SWEATING INCREASES
SNS
91
PNS/SNS: SWEATING CEASES
PNS
92
PNS/SNS: BF TO MM INC , BF TO SKIN AND VISCERA DEC
SNS
93
PNS/SNS: BF TO SKIN AND VISCERA INC
PNS
94
PNS/SNS: ACTIVATION OF MASS MM
SNS
95
PNS/SNS: RELAXATION OF MUSCLES
PNS
96
PNS/SNS: BP INC
SNS
97
PNS/SNS: BRONCHODILATION
SNS
98
(+)/(-) FEATURE OF UMN: PARESIS
-
99
(+)/(-) FEATURE OF UMN: CLONUS
+
100
(+)/(-) FEATURE OF UMN: ASSOCIATED RXN
+
101
(+)/(-) FEATURE OF UMN: FATIGUE
-
102
(+)/(-) FEATURE OF UMN: BABINSKI
+
103
(+)/(-) FEATURE OF UMN: EXAGGERATED DTRS
+
104
(+)/(-) FEATURE OF UMN: SYNERGIES
+
105
(+)/(-) FEATURE OF UMN: LOSS OF DEXTERITY
-
106
(+)/(-) FEATURE OF UMN: DISTURBANCE IN MVT
+
107
JAW REFLEX
CN V
108
BICEPS REFLEX
C5-C6
109
BRACHIORADS REFLEX
C5,C6
110
TRICEPS REFLEX
C6,C7
111
ACHILLES REFLEX
S1-S2
112
LATERAL HAMS REFLEX
S1-S2
113
MEDIAL HAMS REFLEX
L4-L5
114
KNEE JERK
L2,L3,L4
115
UPPER ABDOMINAL REFLEX
T8-T10
116
LOWER ABDOMINAL REFLEX
T10-T12
117
GENERALIZED MUSCLE WEAKNESS
ASTHENIA
118
FLEXOR WITHDRAWAL ONSET AND INTEGRATION
28 WKS OF GESTATION; 1-2 MOS
119
CROSSED EXTENSION ONSET AND INTEGRATION
28 WKS OF GESTATION; 1-2 MOS
120
TRACTION ONSET AND INTEGRATION
28 WKS OF GESTATION; 2-5 MOS
121
MORO ONSET AND INTEGRATION
28 WKS OF GESTATION; 5-6 MOS
122
STARTLE ONSET AND INTEGRATION
AT BIRTH; PERSISTAS
123
GRASP ONSET AND INTEGRATION
PALMAR: BIRTH/PLANTAR: 28 WKS OF GESTATION
PALMAR: 4-6 MOS/PLANTAR: 9 MOS.
124
ATNR ONSET AND INTEGRATION
BIRTH ; 4-6 MOS
125
STNR ONSET AND INTEGRATION
4-6 MOS ; 8- 12 MOS
126
STLR ONSET AND INTEGRATION
BIRTH; 6 MOS
127
ASSOCIATED REACTION ONSET AND INTEGRATION
BIRTH - 3 MOS
| 8-9 YRS
128
POSSITIVE SUPPORTING ONSET AND INTEGRATION
BIRTH; 6 MOS
129
SPINAL/PRIMITIVE REFLEXES
MORO, STARTLE, GRASP, TRACTION, FLEXOR WITHDRAWAL, CROSSED EXTENSION
130
TONIC/BRAINSTEM REFLEXES
ATNR, STNR, STLR, ASSOCIATED RXNS AND POSITIVE SUPPORTING
131
INTRINSIC PATHOLOGY OR D/O
DISEASE
132
ANY LOSS OR ABNORMALITY OF PSYCHOLOGICAL, PHYSIOLOGICAL OR ANATOMICAL STRUCTURE OR FUNCTION
IMPAIRMENT
133
ANY RESTRICTION OR LACK OF ABILITY TO PERFORM AN ACTIVITY IN THE RANGE OF A NORMAL HUMAN
DISABILITY
134
DISADVANTAGE FOR A GIVEN INDIVIDUAL RESULTING FROM AN IMPAIRMENT OR DISABILITY THAT HINDERS THEM TO FULFILL A ROLE THAT IS NORMAL
HANDICAP
135
INTERRUPTION OR INTERFERENCE WITH NORMAL PROCESSES AND EFFORTS OF THE ORGANISM TO REGAIN NORMAL STATE
ACTIVE PATHOLOGY
136
LIMITATION IN PERFORMANCE AT THE LEVEL OF THE WHOLE ORGANISM/PERSON
FUNCTIONAL IMPAIRMENT
137
FEV1 IN MILD COPD
> 80 %
138
FEV1 MODERATE COPD
50-80%
139
FEV1 SEVERE COPD
30-50%
140
FEV1 VERY SEVERE COPD
< 30%
141
TRADENAME AND ACTION: ANTICHOLINERGIC
ATROVENT - BRONCHODILATION
142
TRADENAME AND ACTION: LONG ACTING BETA 2 AGONIST
SEREVENT - BRONCHODILATION
143
SIDE EFFECTS OF ANTICHOLINERGICS
THROAT IRRITATION,
DRYING OF TRACHEAL SECRETIONS
TACHYCARDIA
PALPITATIONS
144
SIDE EFFECTS OF SEREVENT
```
TACHYCARDIA
PALPITATIONS
GI DISTRESS
NERVOUSNESS
TREMOR
H/A
DIZZINESS
```
145
CROMOLYN SODIUM/INTAL: ACTION AND SIDE EFFECT
A: PREVENTS INFLAMMATION
S/E: BRONCHOSPASM
THROAT IRRITATION
COUGH
146
STEROIDS/FLOVENT/PREDNISONE: ACTION AND SIDE EFFECT
```
A: ANTI-INFLAMMATORY
S/E: INC BP
SODIUM RETENTION
MUSCLE WASTING
OSTEOPOROSIS
GI IRRITATION
ATHEROSCLEROSIS
HYPERCHOLESTEROLEMIA
INC SUSCEPTIBILITY TO INFECTION
```
147
LEUKOTRIENE RECEPTOR ANTAGONIST/SINGULAIR: ACTION AND SIDE EFFECT
```
A: BLOCKS ALLERGIC REACTION
S/E: GI DISTRESS
SORE THROAT
URTI
DIZZINESS
H/A AND NASAL CONESTION
```
148
METHYLXANTHINE
AMINOPHYLLINE
| THEOPHYLLINE
149
METHYLXANTHINE: ACTION AND SIDE EFFECT
```
A: BRONCHODILATION
S/E: SEIZURE
CARDIAC ARRHYTHMIAS
GI DISTRESS
TREMOR AND H/A
```
150
NORMAL/MINOR/MAJOR CARDIAC DYSFUNCTION/PEAK:
| CK MB
0-3% / 5% / 10% / 14-36 hrs
151
NORMAL/MINOR/MAJOR CARDIAC DYSFUNCTION/PEAK:
| LDH
127 IU or 100-225 mU/mL / 300-750 mU/ml / >1000 mu/mL
152
NORMAL/MINOR/MAJOR CARDIAC DYSFUNCTION/PEAK:
| TROPONIN
0-0.2 microgram/ml / 5 / 10 / 24-36 hrs
153
NORMAL/MINOR/MAJOR CARDIAC DYSFUNCTION/PEAK:
| MYOGLOBIN
<100 ng/ml / 200ng/ml / > 500 ng/ml
154
HR/BP: BETA BLOCKERS
DEC/DEC
155
HR/BP: NITRATES
INC/DEC
156
HR/BP: CALCIUM CHANNEL BLOCKERS
DEC/DEC
157
HR/BP: DIGITALIS
DEC/NE
158
HR/BP: DIURETICS
NE/NE or dec
159
HR/BP: VASODILATORS
INC/DEC
160
HR/BP: ANTIADRENERGIC AGENTS s selective blockade
DEC/DEC
161
HR/BP: NICOTINE
INC/INC
162
FXNAL CLASS OF pt.s c HEART DSE: CLASS 1
4 - 6 cal/min ; 6.5 METS
without limitation in physical activity
ordinary activity - no sx
163
FXNAL CLASS OF pt.s c HEART DSE: CLASS 2
3-4 cal/min ; 4.5 METS
slight limitation in physical activity
ordinary act - (+) sx
no sx at rest
164
FXNAL CLASS OF pt.s c HEART DSE: CLASS 3
2-3 cal/min; 3 METS
marked limitation in physical activity
less than normal activity - (+) sx
no sx at rest
165
FXNAL CLASS OF pt.s c HEART DSE: CLASS 4
1-2 cal/min ; 1.5 MET
(+) sx with any activity and even at rest
inability to carryout any act without discomfort
166
NORMAL/LV/RV/BV: CVP
0-8 mmHg / 6 mmHg / 12 mmHg / 12 mmHg
167
NORMAL/LV/RV/BV: PAP
9-19 mmHg / 22 mmHg / 16 mmHg / 22 mmHg
168
NORMAL/LV/RV/BV: PCWP
6-12 mmHg / 18 mmHg / 10 mmHg / 18 mmHg
169
ASSOCIATED WITH RV FAILURE
INCREASED CVP
170
ASSOCIATED WITH LV FAILURE
INCREASE PAP AND PCWP
171
INPATIENT CARDIAC REHAB: LEVEL 1
1-1.5 METs - ESSENTIALLY BED REST
ARMS SUPPORTED
BED EXERCISES/SITTING DANGLED WITH FEET SUPPORTED
INTRODUCE TO CARDIAC REHAB
172
INPATIENT CARDIAC REHAB: LEVEL 2
```
1.5-2 METS - LIMITED ROOM AMBULATION
15-30 mins sitting - 3-4x/day
LEG EXERCISES
ELECTRIC RAZOR
COMMODE PRIVILEDGE
HEALING INTERVAL
EDUCATE ON RISK FACTORS
```
173
INPATIENT CARDIAC REHAB: LEVEL 3
```
2-2.5 METS - LIMITED HALL AMBULATION
ROOM OR HALL AMBULATION ~ 5' - 3-4x/day
OPTIONAL STANDING LEG EXERCISES
MANUAL SHAVE
BATHROOM PRIVILEDGE
EDUCATE ON SIZE OF INFARCT AND THE IMPACT OF EXERCISE AND BORG'S RPE
```
174
INPATIENT CARDIAC REHAB: LEVEL 4
2.5-3 METs - PROGRESSIVE HALL AMBULATION
HALL AMBULATION 5-7' - 3-4x/day
STANDING TRUNK EXERCISES
EDUCATE ON PULSE TAKING AND OUTPATIENT CARDIAC REHAB
175
INPATIENT CARDIAC REHAB: LEVEL 5
```
3-4 METS - PROGRESSIVE HALL AMBULATION
HALL AMBULATION ~ 8-10'
ARM EXERCISES OPTIONAL
STANDING SHOWER
WRITTEN HEP
```
176
INPATIENT CARDIAC REHAB: LEVEL 6
4-5 MET - STAIR CLIMBING
| FULL FLIGHT OF STAIRS UP AND DOWN ONE STEP AT A TIME
177
NO EVIDENCE OF HEMODYNAMIC COMPROMISE:
| in the HR of beta blocked and non beta blocked pts.
beta blocked: not >12 bpm
| non: not >20 bpm
178
NO EVIDENCE OF HEMODYNAMIC COMPROMISE: SBP
no drop: >10 mmHg
| no rise: >30 mmHg
179
NO EVIDENCE OF HEMODYNAMIC COMPROMISE: RPE
<13/20
180
NON INVASIVE TEST TO EXAME LE FOR ISCHEMIA, FOLLOWING ELEVATION, LOWERING OF THE LIMB SHOULD RETURN THE SKIN OF THE LIMB TO A PINK COLOR, IF DARK RED AND TAKES >30s = (+) arterial insufficiency
RUBOR TEST FOR DEPENDENCY
181
FOR BOTH ARTERIAL AND VENOUS CIRCULATION, CHANGES IN LE VOLUME TESTED DURING REST, STANDING AND LIGHT WALKING; DETECTS VENOUS OBSTRUCTION AND ARTERIAL INFLOW
AIR PLETHYSMOGRAPHY (APG)
182
FOR ARTERIAL CIRCULATION, SPECIAL PROVE AND A HEATING ELEMENT MEASURE PROFUSION, MEASUREMENT OF OXYGEN AT SKIN LEVEL = what's happening at cellular level
PREDICTIVE FOR HEALING OF ULCERS AND AMPUTATION WOUNDS
TRANSCUTANEOUS OXYGEN (TcPO2)
183
MEASURES BLOOD FLOW IN SKIN using a modified laser doppler probe
PREDICTIVE FOR HEALING OF ULCERS AND AMPUTATION WOUNDS
SKIN PERFUSION PRESSURE (SPP) measurement
184
TIME IT TAKES FOR THE VEINS ON TOP OF FOOT TO REFILL IS RECORDED
VENOUS FILLING TIME
185
VENOUS FILLING TIME:
(N) VALUE
ARTERIAL INSUFFICIENCY
VENOUS INSUFFICIENCY
15s
>15s
<15s
186
LE IN DEPENDENT POSITION, PALPATE GREAT SAPHENOUS VEIN DISTAL TO KNEE with ONE HAND, other hand proximal to knee 6"(15.2cm), percuss,
positive if wave of fluid is felt at distal site = poss VALVULAR INCOMPETENCY
PERCUSSION TEST
187
MEASURES TIME REQUIRED TO REFILL THE VEINS IN THE DORSUM OF THE FOOT; elevate foot, place tourniquet at thigh to prevent backflow
trendelenburg test
188
TRENDELENBURG TEST: if within 5s veins distend before tourniquet is released?
VALVULAR INCOMPETENCE OF DEEP VEINS
189
TRENDELENBURG TEST: if within 5s veins distend after tourniquet is released?
VALVULAR INCOMPETENCE OF SUPERFICIAL VEINS
190
PURPLE OR MAROON LOCALIZED AREA OF DISCOLORED INTACT SKIN OR BLOOD FILLED BLISTER
SUSPECTED DEEP TISSUE INJURY
191
TISSUE IS PAINFUL , FIRM, MUSHY , BOGGY, WARMER OR COOLER COMPARED TO ADJACENT TISSUE
SUSPECTED DEEP TISSUE INJURY
192
INTACT SKIN WITH NONBLANCHABLE REDNESS
STAGE 1
193
AREA MAY BE PAINFUL, FIRM, SOFTER, WARMER, OR COOLER COMPARED TO ADJACENT TISSUE
STAGE 1
194
PARTIAL THICKNESS SKIN LOSS OF DERMIS
STAGE 2
195
SHALLOW OPEN ULCER WITH A RED PINK WOUND BED
STAGE 2
196
FULL THICKNESS TISSUE LOSS , SUB Q VISIBLE
STAGE 3
197
UNDERMINING / TUNNELING
STAGE 4
198
FULL THICKNESS WITH EXPOSED BONE , TENDON, MUSCLE
STAGE 4
199
FULL THICKNESS LOSS, BASE FILLED WITH SLOUGH(YELLOW, TAN, GRAY, GREEN/BROWN) AND ESCHAR
UNSTAGEABLE
200
DRAINAGE: CLEAR
TRANSUDATED
201
DRAINAGE: CLEAR OR TINGE OF RED/BROWN
SEROSANGUINEOUS
202
DRAINAGE: CREAMY, YELLOWISH
EXUDATE
203
DRAINAGE: YELLOW, BROWN
PUS
204
DRAINAGE: HUES OF YELLOW, BLUE, GREEN
INFECTED PUS
205
AFFECTED PRIMARY MOTOR AREA AND MEDIAL ASPECT OF CORTEX AND INTERNAL CAPSULE
C/L HEMIPARESIS LE>UE - ACA
206
AFFECTED PRIMARY SENSORY AREA AND MEDIAL ASPECT OF CORTEX
C/L HEMISENSORY LOSS LE>UE - ACA
207
AFFECTED CORPUS CALLOSUM
PROBLEMS WITH IMITATION AND BIMANUAL TASKS, APRAXIA
208
AFFECTED PM ASPECT OF SUPERIOR FRONTAL GYRUS
URINARY INCONTINENCE
209
VBA OCCLUSION: I/L PARALYSIS WITH ATROPHY OF HALF THE TONGUE WITH DEVIATION TO PARALYZED SIDE WHEN TONGUE IS PROTRUDED
MEDIAL MEDULLARY SYNDROME
210
VBA OCCLUSION: TETRAPLEGIA
COMPLETE BASILARY ARTERY OR LOCKED IN
211
VBA OCCLUSION: DYSPHAGIA AND DYSPHONIA
HORNER'S SYNDROME
212
VBA OCCLUSION: I/L PARALYSIS OF CONJUGATE GAZE TO SIDE OF LESION
MEDIAL AND LATERAL INFERIOR PONTINE SYNDROME
213
VBA OCCLUSION: I/L NYSTAGMUS
WALLENBURG AND MEDIAL INFERIOR PONTINE SYNDROME
214
VBA OCCLUSION: DEAFNESS AND TINNITUS
LATERAL INFERIOR PONTINE SYNDROME
215
VBA OCCLUSION: I/L DIPLOPIA AT LATERAL GAZE
MEDIAL INFERIOR PONTINE
216
VBA OCCLUSION: (B) CRANIAL NN PALSY
COMPLETE BASILAR ARTERY
217
VBA OCCLUSION: COMA
COMPLETE BASILAR ARTERY
218
VBA OCCLUSION: HORIZONTAL AND VERTICAL NYSTAGMUS, NAUSEA, VOMITING AND VERTIGO
LATERAL INFERIOR PONTINE
219
VBA OCCLUSION: IMPAIRED TACTILE AND PROPRIOCEPTIVE SENSE
MEDIAL MEDULLARY AND MEDIAL INFERIOR PONTINE
220
VBA OCCLUSION: LIMB AND GAIT ATAXIA
LATERAL MEDULLARY AND MEDIAL INFERIOR PONTINE
221
VBA OCCLUSION: C/L IMPAIRED PAIN AND THERMAL SENSE OVER 50% OF BODY
HORNERS AND LATERAL INFERIOR PONTINE SYNDROME
222
VBA OCCLUSION: DEVIATION OF EYES
MEDIAL MIDPONTINE SYNDROME
223
VBA OCCLUSION: ATAXIA OF LIMBS
MEDIAL AND LATERAL MIDPONTINE SYNDROME
224
VBA OCCLUSION: PARALYSIS OF MM OF MASTICATION
LATERAL MIDPONTINE SYNDROME
225
VBA OCCLUSION: INTERNUCLEAR OPTHALMOPLEGIA
MEDIAL SUPERIOR PONTINE SYNDROME
226
VBA OCCLUSION: LOSS OF OPTOKINETIC NYSTAGMUS
LATERAL SUPERIOR PONTINE SYNDROME
227
VBA OCCLUSION: LOSS OF TOUCH VIBRATION AND POSITION SENSE MORE IN LE THAN UE
LATERAL SUPERIOR PONTINE SYNDROME
